Further Evidence that Activated Protein C Resistance Affects Protein C Coagulant Activity Assays

• References

• 1 Simioni P, Sanson B, Prandoni P, Tormene D, Friederich PW, Girolami B, Gavasso S, Huisman MV, Büller HR, ten Cate JW, Girolami A, Prins MH. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81: 198-202.
• 2 Ireland H, Bayston T, Thompson E, Adami A, Goncalves C, Lane DA, Finazzi G, Barbui T. Apparent heterozygous type II protein C deficiency caused by the factor V 506 Arg to Gln mutation. Thromb Haemost 1995; 731-2.
• 3 Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Ischemic stroke in young patients with activated protein C resistance: a report of three cases belonging to three different kindreds. Stroke 1995; 26: 885-90.
• 4 Faioni EM, Franchi F, Asti D, Mannucci PM. Resistance to activated protein C mimiking dysfunctional protein C: diagnostic approach. Blood Coagulation and Fibrinolysis 1996; 07: 349-52.
• 5 Faioni EM, Franchi F, Asti D, Sacchi E, Bernardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost 1993; 70: 1067-71.
• 6 Cooper PC, Hampton KK, Makris M, Abuzenadah A, Paul B, Preston FE. Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency. Br J Haematol 1994; 88: 201-3.